Clinical Trials Directory

Trials / Terminated

TerminatedNCT03591861

Therapeutic Targeting of Sex Differences in Pediatric Brain Tumor Glycolysis

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
2 (actual)
Sponsor
Washington University School of Medicine · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

The investigators will develop the concept of a sex-specific therapeutic intervention for gliomas that is based upon dietary carbohydrate restriction. The investigators will integrate metabolomics tools and FDG-PET imaging to validate the ketogenic diet on a sex-specific basis.

Conditions

Interventions

TypeNameDescription
PROCEDUREKetogenic diet* Children under 2 years will immediately start on a full calorie classical 3:1 ketogenic diet. The 3:1 ratio indicates that the diet contains 3 g of fat for every 1 g of protein + carbohydrate, which results in about 87% of calories coming from fat. * Children 2 years or older will skip breakfast and lunch on the day of admission but start a full calorie 3:1 ketogenic diet at dinner.
DRUGBCNU-Standard of care

Timeline

Start date
2019-05-01
Primary completion
2022-11-01
Completion
2022-11-01
First posted
2018-07-19
Last updated
2022-12-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03591861. Inclusion in this directory is not an endorsement.

Therapeutic Targeting of Sex Differences in Pediatric Brain Tumor Glycolysis (NCT03591861) · Clinical Trials Directory